Sort
23,748 grants matching “melanoma”
Oncogenic Kit receptor signaling in vivo
$474,750Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2011 · HL
Oncogenic Kit receptor signaling in vivo
$474,750Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2010 · HL
Molecular Basis of Parvoviral Target Cell Specificity
$474,706Peter Tattersall · Yale University · R01 · FY2014 · CA
Molecular Structure and Function of Crystallins
$474,698Graeme J Wistow · National Eye Institute · Z01 · FY2008 · EY
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA
$474,575Hsian-Rong Tseng · University Of California Los Angeles · P01 · FY2013 · CA
Mcl-1 in apoptosis and signal transduction: a structure/function approach
$474,252Maurizio Pellecchia · University Of California Riverside · R01 · FY2016 · CA
Project 2: Primary melanoma DNA Methylation profiling for evaluating subtypes and survival
$474,165Nancy E Thomas · University Of New Mexico Health Scis Ctr · P01 · FY2019 · CA
Neoadjuvant immunotherapy approaches to early stage melanoma
$474,126Meenhard Herlyn · Wistar Institute · P50 · FY2025 · CA
Therapeutically harnessing anti-viral resident memory T cells in solid tumors
$474,122Pamela Rosato · Dartmouth College · R01 · FY2024 · CA
CELL SURFACE STRUCTURE AND TRANSFORMATIONS
$473,976Massachusetts Institute Of Technology · R01 · FY2002 · CA
The regulation of melanocyte stem cells by Wnt signaling
$473,958Mayumi Ito · New York University School Of Medicine · R01 · FY2022 · AR
Nanoparticles to Track T Cell Immunotherapy Using Magnetic Particle Imaging
$473,925Carlos M Rinaldi-Ramos · University Of Florida · R01 · FY2025 · EB
Computational Methods for Identifying Non-coding Cancer Drivers
$473,876Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
ACADEMIC CLINICAL ONCOLOGIST TRAINING PROGRAM
$473,799University Of Wisconsin Madison · K12 · FY2003 · CA
Targeting UHRF1 in combinational immunotherapy
$473,749Xiao-Fan Wang · Duke University · R01 · FY2019 · CA
PD-1/PD-L1 modulation in cancer therapy
$473,681Drew M. Pardoll · Johns Hopkins University · R01 · FY2019 · CA
Expanding the tumor antigen landscape and maintaining APCs in a T cell-activating state to restore tumor immunity
$473,680Eduardo Davila · University Of Colorado Denver · R01 · FY2025 · CA
Developmental Funds
$473,632Juanita L Merchant · University Of Arizona · P30 · FY2025 · CA
Overcoming resistance to targeted therapy in cancer
$473,472Levi Alexander Garraway · Dana-Farber Cancer Inst · R35 · FY2015 · CA
Determining the clinical impact of gene expression testing in localized prostate cancer
$473,428Todd M. Morgan · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Molecular Mechanism and Therapy for Ocular Melanoma
$473,364Joan Heller Brown · University Of California, San Diego · R01 · FY2019 · CA
An integrated polymeric carrier for subunit cancer vaccines
$473,251Suzie H Pun · University Of Washington · R01 · FY2023 · CA
The regulation of melanocyte stem cells by Wnt signaling
$473,227Mayumi Ito · New York University School Of Medicine · R01 · FY2021 · AR
Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells
$473,214Qing Yi · Methodist Hospital Research Institute · R01 · FY2025 · CA
Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells
$473,214Qing Yi · Methodist Hospital Research Institute · R01 · FY2023 · CA